Skip to content

Role of phyto-oestrogens (Cimicifuga racimosa) in combination with clomiphene citrate on ovulation induction in women with polycystic ovarian syndrome

Role of phyto-oestrogens (Cimicifuga racimosa) in combination with clomiphene citrate on ovulation induction in women with poly-cystic ovarian syndrome, A clinical Trial study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020264N2
Enrollment
100
Registered
2018-01-04
Start date
2016-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrom. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: 20 mg Cimicifuga racimosa twice a day for 10 days with clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menst
Treatment - Drugs
Intervention group: 20 mg Cimicifuga racimosa twice a day for 10 days with clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menstrual cycle and w
Control group: clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menstrual cycle and will be prescribed for three consecutive cycles.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Women with polycystic ovarian syndrome Primary and secondary infertility Normal hysterosalpingography Normal Spermogram in patients' spouses Age below 38 years

Exclusion criteria

Exclusion criteria: History of cardiovascular disease History of liver disease History Ovarian masses

Design outcomes

Primary

MeasureTime frame
Plasma estradiol. Timepoint: 12 days after intervention. Method of measurement: sonography.

Secondary

MeasureTime frame
Endometrial thickness. Timepoint: 12 days after intervention. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Mahmoodo Nia

Mashhad University of Medical Sciences

mahmodynia@gmail.com+98 51 3802 2608

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026